FAKTOR-FAKTOR KEBERHASILAN PENGOBATAN PASIEN TUBERKULOSIS RESISTEN RIFAMPISIN (TB-RR) DI PROVINSI JAMBI
Keywords:
Treatment success, tuberculosis, rifampicin resistance, JambiAbstract
The success rate of drug-resistant tuberculosis (DR-TB) treatment in Jambi Province has not yet reached the target. This study aims to determine factors contributing to treatment success in patients with rifampicin-resistant tuberculosis (RR-TB) in Jambi Province. The study was conducted in Jambi Province using a retrospective cohort design. Data were obtained from the Tuberculosis Information System (SITB) for the period 2020–2023. A total of 122 patients were included using a total sampling technique. The inclusion criteria comprised patients who received treatment between 2020 and 2023 with complete data. Exclusion criteria included patients who had not completed treatment, had incomplete or duplicate data, or whose treatment outcomes had not been evaluated. The instrument used was the TB RO.03 report. Data were analyzed using the Chi-square test and log-linear Poisson regression. The treatment success rate for RR-TB was 61.5%. Age was significantly associated with treatment success, with an adjusted relative risk (aRR) of 1.65 (95% CI: 1.03–2.66). In contrast, no significant associations were found between treatment success and gender, history of previous treatment, anti-tuberculosis drug regimen, diabetes mellitus status, or HIV status. Age was identified as the most dominant factor influencing treatment success. Therefore, special attention should be given to patients aged over 50 years to improve TB treatment outcomes.
References
Adawiyah, R. N., Akaputra, R., Ratri, M., & Fachri, M. (2023). Faktor – Faktor yang Mempengaruhi Lama Waktu Pengobatan Tuberkulosis Paru Klinis di Rumah Sakit Umum Daerah Pasar Minggu Tahun 2019 - 2023. Jurnal Universitas Muhammadiyah Jakarta, (January 2019), 1–13.
Aviana, F., Jati, S. P., & Budiyanti, R. T. (2021). Systematic Review Pelaksanaan Programmatic Management of Drug-Resistant Tuberculosis Pada Pasien Tuberkulosis Resistan Obat. Jurnal Kesehatan Masyarakat (Undip), 9(2), 215–222. https://doi.org/10.14710/jkm.v9i2.28719
Dalimunthe, M. S. R., Susanti, N., Aidha, Z., & Batubara, A. K. (2025). The The Determinants of Drug-Resistant Tuberculosis Incidence at the Special Lung Hospital, Health Department of the Provincial Government of North Sumatera, 2021-2024. MEDFARM: Jurnal Farmasi Dan Kesehatan, 14(1), 254–267. https://doi.org/10.48191/medfarm.v14i1.539
Dlatu, N., Faye, L. M., & Apalata, T. (2025). Outcomes of Treating Tuberculosis Patients with Drug-Resistant Tuberculosis, Human Immunodeficiency Virus, and Nutritional Status: The Combined Impact of Triple Challenges in Rural Eastern Cape. International Journal of Environmental Research and Public Health, 22(3). https://doi.org/10.3390/ijerph22030319
Fekadu, G., Turi, E., Kasu, T., Bekele, F., Chelkeba, L., Tolossa, T., Labata, B. G., Dugassa, D., Fetensa, G., & Diriba, D. C. (2020). Impact of HIV status and predictors of successful treatment outcomes among tuberculosis patients: A six-year retrospective cohort study. Annals of Medicine and Surgery, 60(November), 531–541. https://doi.org/10.1016/j.amsu.2020.11.032
Hantoro, N. M., & Dkk. (2023). Parliamentary Review. Parliamentary Review, 4(4), 141–199.
Karataş, M., Dirie, A., Çolakoğlu, S., Hussein, A., & Ali, A. (2024). Tuberculosis Treatment Outcomes and Associated Factors in Benadir Somalia. A Multicenter Cohort Study. International Journal of General Medicine, Volume 17(June), 2711–2718. https://doi.org/10.2147/ijgm.s463237
Kemenkes RI. (2023). Laporan Penangulangan Tuberkulosis. Kemenkes RI, 1–156. https://www.tbindonesia.or.id/wp-content/uploads/2024/12/Laporan-Program-Penanggulangan-TBC-2023_Final.pdf
Kementerian Kesehatan Republik Indonesia. (2020). Petunjuk Teknis Penatalaksanaan Tuberkulosis Resistan Obat di Indonesia. Kemenkes RI. https://www.tbindonesia.or.id/wp-content/uploads/2021/06/TBRO_Buku-Juknis-Tuberkulosis-2020-Website.pdf
Kementerian Kesehatan Republik Indonesia. (2024). Petunjuk Teknis Penatalaksanaan Tuberkulosis Resistan Obat di Indonesia.
Kementerian Kesehatan Republik Indonesia. (2025). Aksi Nyata Percepatan Eliminasi Tuberkulosis di Indonesia. Kemenkes RI. https://kemkes.go.id/id/47510
Mleoh, L., Mziray, S. R., Tsere, D., Koppelaar, I., Mulder, C., & Lyakurwa, D. (2023). Shorter regimens improved treatment outcomes of multidrug-resistant tuberculosis patients in Tanzania in 2018 cohort. Tropical Medicine and International Health, 28(5), 357–366. https://doi.org/10.1111/tmi.13867
Pakasi, T. T. (2024). Update Situasi Tuberkulosis Resistan Obat di Indonesia. Kemenkes RI. document/811342635/01-Update-Situasi-TBC-RO-di-Indonesia?
Panford, V., Kumah, E., Kokuro, C., Adoma, P. O., Baidoo, M. A., Fusheini, A., Ankomah, S. E., Agyei, S. K., & Agyei-Baffour, P. (2022). Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Ashanti Region, Ghana: a retrospective, cross-sectional study. BMJ Open, 12(7), 1–9. https://doi.org/10.1136/bmjopen-2022-062857
Wang, X., Zhang, Q., & Wu, W. (2020). Unusual Tuberculosis of the Frontal Bone: A Case Report. Open Journal of Internal Medicine, 10(04), 321–325. https://doi.org/10.4236/ojim.2020.104033
WHO. (2024a). Global tuberculosis report. In 25 November 2024. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2024
WHO. (2024b). TB Incidence Global TB Report 2024. World Health Organization. https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024/tb-disease-burden/1-1-tb-incidence?utm_source=chatgpt.com
Xu, G., Hu, X., Lian, Y., & Li, X. (2023). Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infectious Diseases, 23(1), 1–13. https://doi.org/10.1186/s12879-023-08765-0
Zhao, L., Gao, F., Zheng, C., & Sun, X. (2024). The Impact of Optimal Glycemic Control on Tuberculosis Treatment Outcomes in Patients With Diabetes Mellitus: Systematic Review and Meta-Analysis. JMIR Public Health Surveill, 10, e53948. https://doi.org/10.2196/53948
